Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan

Yuko Kaneko, Takao Koike, Hiromi Oda, Kazuhiko Yamamoto, Nobuyuki Miyasaka, Masayoshi Harigai, Hisashi Yamanaka, Naoki Ishiguro, Yoshiya Tanaka, Tsutomu Takeuchi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective. To clarify the obstacles preventing the implementation of the treat-to-target (T2T) strategy for rheumatoid arthritis (RA) in clinical practice. Methods. A total of 301 rheumatologists in Japan completed a questionnaire. In the fi rst section, participants were indirectly questioned on the implementation of basic components of T2T, and in the second section, participants were directly questioned on their level of agreement and application. Results. Although nearly all participants set treatment targets for the majority of RA patients with moderate to high disease activity, the proportion who set clinical remission as their target was 59%, with only 45% of these using composite measures. The proportion of participants who monitored X-rays and Health Assessment Questionnaires for all their patients was 44% and 14%, respectively. The proportion of participants who did not discuss treatment strategies was 44%, with approximately half of these reasoning that this was due to a proportion of patients having a lack of understanding of the treatment strategy or inability to make decisions. When participants were directly questioned, there was a high level of agreement with the T2T recommendations. Conclusion. Although there was a high level of agreement with the T2T recommendations, major obstacles preventing its full implementation still remain.

Original languageEnglish
Pages (from-to)43-49
Number of pages7
JournalModern Rheumatology
Volume25
Issue number1
DOIs
Publication statusPublished - 2015

Fingerprint

Rheumatoid Arthritis
Japan
Therapeutics
X-Rays
Health
Surveys and Questionnaires
Rheumatologists

Keywords

  • Implementation
  • Obstacle
  • Rheumatoid arthritis
  • Treat-to-target

ASJC Scopus subject areas

  • Rheumatology

Cite this

Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan. / Kaneko, Yuko; Koike, Takao; Oda, Hiromi; Yamamoto, Kazuhiko; Miyasaka, Nobuyuki; Harigai, Masayoshi; Yamanaka, Hisashi; Ishiguro, Naoki; Tanaka, Yoshiya; Takeuchi, Tsutomu.

In: Modern Rheumatology, Vol. 25, No. 1, 2015, p. 43-49.

Research output: Contribution to journalArticle

Kaneko, Yuko ; Koike, Takao ; Oda, Hiromi ; Yamamoto, Kazuhiko ; Miyasaka, Nobuyuki ; Harigai, Masayoshi ; Yamanaka, Hisashi ; Ishiguro, Naoki ; Tanaka, Yoshiya ; Takeuchi, Tsutomu. / Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan. In: Modern Rheumatology. 2015 ; Vol. 25, No. 1. pp. 43-49.
@article{2bde77ace6e345e0b457109d05a2807a,
title = "Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan",
abstract = "Objective. To clarify the obstacles preventing the implementation of the treat-to-target (T2T) strategy for rheumatoid arthritis (RA) in clinical practice. Methods. A total of 301 rheumatologists in Japan completed a questionnaire. In the fi rst section, participants were indirectly questioned on the implementation of basic components of T2T, and in the second section, participants were directly questioned on their level of agreement and application. Results. Although nearly all participants set treatment targets for the majority of RA patients with moderate to high disease activity, the proportion who set clinical remission as their target was 59{\%}, with only 45{\%} of these using composite measures. The proportion of participants who monitored X-rays and Health Assessment Questionnaires for all their patients was 44{\%} and 14{\%}, respectively. The proportion of participants who did not discuss treatment strategies was 44{\%}, with approximately half of these reasoning that this was due to a proportion of patients having a lack of understanding of the treatment strategy or inability to make decisions. When participants were directly questioned, there was a high level of agreement with the T2T recommendations. Conclusion. Although there was a high level of agreement with the T2T recommendations, major obstacles preventing its full implementation still remain.",
keywords = "Implementation, Obstacle, Rheumatoid arthritis, Treat-to-target",
author = "Yuko Kaneko and Takao Koike and Hiromi Oda and Kazuhiko Yamamoto and Nobuyuki Miyasaka and Masayoshi Harigai and Hisashi Yamanaka and Naoki Ishiguro and Yoshiya Tanaka and Tsutomu Takeuchi",
year = "2015",
doi = "10.3109/14397595.2014.926607",
language = "English",
volume = "25",
pages = "43--49",
journal = "Modern Rheumatology",
issn = "1439-7595",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan

AU - Kaneko, Yuko

AU - Koike, Takao

AU - Oda, Hiromi

AU - Yamamoto, Kazuhiko

AU - Miyasaka, Nobuyuki

AU - Harigai, Masayoshi

AU - Yamanaka, Hisashi

AU - Ishiguro, Naoki

AU - Tanaka, Yoshiya

AU - Takeuchi, Tsutomu

PY - 2015

Y1 - 2015

N2 - Objective. To clarify the obstacles preventing the implementation of the treat-to-target (T2T) strategy for rheumatoid arthritis (RA) in clinical practice. Methods. A total of 301 rheumatologists in Japan completed a questionnaire. In the fi rst section, participants were indirectly questioned on the implementation of basic components of T2T, and in the second section, participants were directly questioned on their level of agreement and application. Results. Although nearly all participants set treatment targets for the majority of RA patients with moderate to high disease activity, the proportion who set clinical remission as their target was 59%, with only 45% of these using composite measures. The proportion of participants who monitored X-rays and Health Assessment Questionnaires for all their patients was 44% and 14%, respectively. The proportion of participants who did not discuss treatment strategies was 44%, with approximately half of these reasoning that this was due to a proportion of patients having a lack of understanding of the treatment strategy or inability to make decisions. When participants were directly questioned, there was a high level of agreement with the T2T recommendations. Conclusion. Although there was a high level of agreement with the T2T recommendations, major obstacles preventing its full implementation still remain.

AB - Objective. To clarify the obstacles preventing the implementation of the treat-to-target (T2T) strategy for rheumatoid arthritis (RA) in clinical practice. Methods. A total of 301 rheumatologists in Japan completed a questionnaire. In the fi rst section, participants were indirectly questioned on the implementation of basic components of T2T, and in the second section, participants were directly questioned on their level of agreement and application. Results. Although nearly all participants set treatment targets for the majority of RA patients with moderate to high disease activity, the proportion who set clinical remission as their target was 59%, with only 45% of these using composite measures. The proportion of participants who monitored X-rays and Health Assessment Questionnaires for all their patients was 44% and 14%, respectively. The proportion of participants who did not discuss treatment strategies was 44%, with approximately half of these reasoning that this was due to a proportion of patients having a lack of understanding of the treatment strategy or inability to make decisions. When participants were directly questioned, there was a high level of agreement with the T2T recommendations. Conclusion. Although there was a high level of agreement with the T2T recommendations, major obstacles preventing its full implementation still remain.

KW - Implementation

KW - Obstacle

KW - Rheumatoid arthritis

KW - Treat-to-target

UR - http://www.scopus.com/inward/record.url?scp=84983457256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983457256&partnerID=8YFLogxK

U2 - 10.3109/14397595.2014.926607

DO - 10.3109/14397595.2014.926607

M3 - Article

C2 - 24950169

AN - SCOPUS:84983457256

VL - 25

SP - 43

EP - 49

JO - Modern Rheumatology

JF - Modern Rheumatology

SN - 1439-7595

IS - 1

ER -